A Randomized Trial of Cerclage Versus 17 α-Hydroxyprogesterone Caproate for Treatment of a Short Cervix
Status:
Terminated
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
We hypothesized that weekly intramuscular injections of 17 hydroxyprogesterone caproate(17P)
will reduce the number spontaneous preterm births prior to 35 weeks gestation when compared
to cerclage therapy. The purpose of this study was to compare medical therapy with 17P to
surgical therapy with transvaginal cerclage in patients with an ultrasound diagnosed short
cervix and funnel in the mid-trimester.